Furthermore, inhibition of CYCLIN D:CDK4/6 activity has been shown to abrogate proliferation in T-ALL cell lines and primary human cells as well as progression of disease in animal models of T-ALL [14, 15]. The gene discussed is CDK4; the disease is acute lymphoblastic leukemia.